Haihua Xie

Dr. Haihua Xie


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
HXHaihua Xie
Haihua Xie
JJJia Jiang
Jia Jiang
SCSihui Cao
Sihui Cao
XXXuan Xu
Xuan Xu
JZJingying ZHOU
Jingying ZHOU
MLMi Liu
Mi Liu
Mild cognitive impairment (MCI) represents a transitional stage between normal aging and dementia, often considered critical for dementia prevention. Despite its significance, no effective clinical treatment for MCI has yet been established. Emerging evidence has demonstrated a strong association between trimethylamine-N-oxide (TMAO), a prominent metabolite derived from the gut microbiota, and MCI, highlighting its potential as a biomarker and therapeutic target. TMAO has been implicated in increasing MCI risk through its influence on factors such as hypertension, cardiovascular disease, depression, diabetes, and stroke. Moreover, it contributes to MCI by promoting oxidative stress, disrupting the blood–brain barrier, impairing synaptic plasticity, inducing inflammation, causing mitochondrial metabolic disturbances, and facilitating abnormal protein aggregation. This review further explores therapeutic strategies targeting TMAO to mitigate MCI progression.

7 May 2025 in BMJ Open
Verified
Journal Article
Open access
PDF file
HXHaihua Xie
Haihua Xie
RZRuhan Zhang
Ruhan Zhang
SCSihui Cao
Sihui Cao
JJJia Jiang
Jia Jiang
BHBo Huang
Bo Huang
LPLiang Peng
Liang Peng
Introduction Approximately 70% of patients with stroke experience varying degrees of cognitive impairment, which imposes a substantial direct and indirect socioeconomic burden. Previous studies have shown that scalp acupuncture (SA) or repetitive transcranial magnetic stimulation (rTMS) in combination with other therapies is effective for poststroke cognitive impairment (PSCI). Limited by interstudy heterogeneity and the limited number of included studies, there is insufficient evidence of the efficacy of rTMS in combination with SA in treating PSCI. Therefore, this protocol aims to investigate the effectiveness of rTMS in conjunction with SA for patients with PSCI through a comprehensive meta-analysis. Methods and analysis This study will undertake a comprehensive search across nine distinct databases (Web of Science, Embase, Cochrane Library, PubMed, China National Knowledge Infrastructure, Wanfang Data, China Science and Technology Journal Database, China Biology Medicine and SCOPUS). The primary outcome will encompass the Montreal Cognitive Assessment and the Mini-Mental State Examination. The secondary outcomes are the modified Barthel Index, the Rivermead Behavioral Memory Test and the Digit Span Test. The bias risk assessment tool from the Cochrane Handbook for Systematic Reviews of Interventions will be used to evaluate bias risk, and the GRADE will be applied to gauge the quality of evidence. Furthermore, we plan to perform an analysis of subgroups to investigate the heterogeneity, employ the leave-one-out approach for sensitivity evaluation and use funnel plots and Egger’s test to determine publication bias, respectively. Ethics and dissemination Ethical approval is not required in systematic review and meta-analysis. The review will be published in a peer-reviewed journal. PROSPERO registration number CRD42024571762.

7 October 2022 in Medicine
Verified
Journal Article
Open access
HXHaihua Xie
Haihua Xie
DXDan Mm Xiong
Dan Mm Xiong
PZPan Mm Zhu
Pan Mm Zhu
HLHao Li
Hao Li
HZHong Zhang
Hong Zhang
NZNing Zhao
Ning Zhao
Background: Approximately 23% to 55% of patients have memory impairments with a greatly negative effect on daily life 3 months after stroke. Repetitive transcranial magnetic stimulation (rTMS) has been widely used in the rehabilitation of stroke as it is safe, painless, and noninvasive. Moreover, few studies have investigated the effect of rTMS on poststroke memory disorder (PSMD). However, the efficacy of rTMS is not consistent and the optional stimulation frequency is unclear. Therefore, this protocol aims to evaluate the clinical effect and safety of rTMS on PSMD by analyzing results from randomized controlled trials. Methods: Search strategies will be performed on seven databases: PubMed, EMBASE, CENTRAL, Chinese Biomedical Literature Database (CBM), Chinese National Knowledge Infrastructure (CNKI), Wan Fang, and Technology Periodical Database (VIP). Only randomized controlled trials registered before August 2021 will be included. Additionally, the language will be limited to English or Chinese. For the outcome, we will focus on the Rivermead Behavioral Memory Test. Additionally, the Montreal Cognitive Assessment, Mini-mental State Examination, Modified Barthel Index, and advent events will be included. Two authors will independently select the study, extract data, and assess quality. Moreover, disagreements will be resolved by the third author. STATA 14 and Review Manager 5.4 will be used to perform the analysis. We will evaluate bias risk in accordance with the Cochrane Handbook for Systematic Reviews of Interventions. To assess the quality of evidence, the Grading of Recommendations Assessment, Development, and Evaluation method will be employed. Results: This study will provide a comprehensive analysis of the current evidence on rTMS for PSMD. Conclusion: A reliable conclusion regarding whether rTMS is an effective and safe intervention for patients with PSMD and the effect of stimulation frequency and sham stimulation will be provided. This study will provide new insights for TMS in treating PSMD, and offer appropriate treatmentoptions to patients and clinicians. PROSPERO registration number: CRD42021282439.

17 April 2026 in Complementary Therapies in Medicine
Verified
Journal Article
Open access
BHBo Huang
Bo Huang
HXHaihua Xie
Haihua Xie
MDMiaomiao Duan
Miaomiao Duan
YCYimin Chen
Yimin Chen
PMPanpan Mu
Panpan Mu
LPLiang Peng
Liang Peng
Chronic non-specific low back pain (cNLBP) is a pervasive and debilitating condition with significant personal, societal, and economic burdens. Despite its prevalence, effective and sustainable non-pharmacological treatment options remain limited. Here, we compared the efficacy of Tuina versus non-Tuina interventions in adults with cNLBP. PubMed, EMBASE, Web of Science, Cochrane Library, CNKI, CBM, WanFang, and VIP were searched from inception to April 2025. The Cochrane Risk of Bias tool and the GRADE approach were applied to assess risk of bias and certainty of evidence. Twenty-one trials (1612 participants) were included. Compared with control interventions, Tuina showed greater pain reduction (SMD = -1.06, 95% CI: [-1.37, -0.76], p < 0.00001, GRADE: low), better functional improvement (SMD = -1.17, 95% CI: [-1.62, -0.72], p < 0.00001, GRADE: low), and superior clinical effectiveness (OR = 3.84, 95% CI: [2.42, 6.11], p < 0.00001, GRADE: low). No significant differences were found in muscle fitness (SMD = 1.42, 95% CI: [-0.00, 2.83], p = 0.05, GRADE: very low) or incidence of serious adverse events. Tuina effectively treats cNLBP, offering substantial pain relief and functional improvements, though it has no significant impact on muscle fitness. Future work should consider standardized protocols and more rigorously designed trials to support clinical recommendations. This study has been registered with the PROSPERO platform (registration no. CRD420251051014).

24 April 2025
Verified
Book Chapter
Open access
PDF file
MLMi Liu
Mi Liu
SCSihui Cao
Sihui Cao
HXHaihua Xie
Haihua Xie
JJJia Jiang
Jia Jiang
WLWeiai Liu
Weiai Liu
PLPenghui Lu
Penghui Lu
The gut microbiota constitutes a complex ecosystem, and its composition and function are intricately linked to human health. Dysbiosis of the gut microbiota is closely associated with the onset and progression of various diseases, including gastrointestinal, immune system, metabolic, and neurological disorders. Consequently, modulating the gut microbiota to reestablish its balance has emerged as a crucial strategy for the prevention and treatment of these diseases. This chapter will delve into the roles of complementary and alternative therapies, such as acupuncture, massage, Chinese herbal medicine, dietary therapy, exercise, and psychological interventions, in modulating the gut microbiota. It will underscore the significant role of these therapies as a beneficial complement to modern medicine in the context of holistic pathology. These complementary and alternative therapies not only modulate the gut microbiota but also enhance the physiological functions of the human body and improve the body’s self-healing ability through holistic regulation. These therapies offer unique advantages in clinical applications, such as fewer side effects, simple operations, and easy integration into daily life. By systematically analyzing the mechanisms of action and clinical application prospects of these therapies, this chapter aims to provide readers with a comprehensive and in-depth perspective to understand the significant value of complementary and alternative therapies in gut microbiota modulation and to offer references for future research and clinical applications.

13 April 2026
Verified
Book Chapter
Open access
PDF file
MLMi Liu
Mi Liu
HXHaihua Xie
Haihua Xie
SCSihui Cao
Sihui Cao
JJJia Jiang
Jia Jiang
WLWeiai Liu
Weiai Liu
PLPenghui Lu
Penghui Lu
Functional dyspepsia (FD) is a common functional gastrointestinal disorder that can be classified into two subtypes: postprandial distress syndrome (PDS) and epigastric pain syndrome (EPS). Although this disease does not increase mortality, its symptoms significantly reduce patients’ quality of life and impose a heavy economic burden on both society and individuals due to frequent medical visits and decreased productivity. To alleviate physical and mental distress, many patients turn to complementary and alternative medicine (CAM). However, given the diversity of CAM therapies, their safety and efficacy still require conclusive evidence for validation; if proven effective, they are expected to be incorporated into the standard treatment regimen for FD. Currently, methods such as traditional Chinese medicine, acupuncture, moxibustion, massage, and dietary therapy have demonstrated the potential to alleviate FD symptoms and improve patients’ health conditions. Therefore, obtaining high-quality evidence regarding their efficacy and safety through randomized controlled trials (RCTs) is crucial for promoting the widespread application of CAM. This section will provide an overview of the clinical trial findings and underlying mechanisms related to CAM.